Effects of Psilocybin in Post-Treatment Lyme Disease
NCT05305105
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Post-Treatment Lyme Disease
Chronic Lyme Disease
Lyme Disease, Chronic
Interventions
DRUG:
Psilocybin
Sponsor
Johns Hopkins University
Collaborators
[object Object]
[object Object]